Oragenics OGEN 深 沪
等待开盘 12-18 09:30:00 美东时间
0.8249
-0.001
-0.13%
华盛通- 最 高0.8349
- 今 开0.82
- 成交量 4.22万股
- 最 低 0.82
- 昨 收 0.826
- 总市值 343.83万
- 52周最高 18.897
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 0.82
- 委 比 0.00%
- 总股本 416.82万
- 历史最高 83700.00
- 量 比 0.30
- 振 幅 1.80%
- 历史最低 0.82
- 每 手 1
- 风险率 3.43%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Reported November 7, 2025: Oragenics Q3 EPS $(1.96) Up From $(11.32) YoY
Oragenics (AMEX:OGEN) reported quarterly losses of $(1.96) per share. This is a 82.69 percent increase over losses of $(11.32) per share from the same period last year.
11-12 21:38
Ocugen to Host Webcast on Wednesday, November 5 at 8:30 A.M. ET to Discuss Business Updates and Third Quarter 2025 Financial Results
Ocugen, Inc. will host a conference call and live webcast on November 5, 2025, at 8:30 a.m. ET to discuss its third quarter 2025 financial results and provide a business update. A pre-market earnings announcement will be issued on the same day. Participants can dial (800) 715-9871 (U.S.) or (646) 307-1963 (international) using conference ID 3029428. The webcast will be available on Ocugen's investor site, along with an archive for 45 days post-ev...
10-23 11:30
Oragenics Regains NYSE Compliance After Public Offering
Oragenics ( ($OGEN) ) just unveiled an update. On October 16, 2025, Oragenics s...
10-21 20:17
Oragenics Regains Nasdaq Compliance
Oragenics, Inc. (NYSE American: OGEN), a clinical-stage biotechnology company developing brain-targeted therapeutics through proprietary intranasal delivery technology, announced today that it has regained full
10-21 20:01
国富氢能住宅氢能储能系统首进摩洛哥酒店
2025年10月13日，江苏国富氢能技术装备股份有限公司（以下简称 “国富氢能”）与 GF HYDROGEN AFRICA 正式签约，共同推进摩洛哥阿加迪尔绿色...
10-20 07:06
Oragenics announces partnership with Receptor.AI
Oragenics (NYSE:OGEN) on Tuesday said that it has collaboreted with Receptor.AI, an artificial intelligence-driven drug profiling company, to accelerate the development of its neurological drug pipeli...
10-07 20:41
Neogen Chemicals Ltd. Reports Successful AGM with All Resolutions Approved
Neogen Chemicals Ltd. ( ($IN:NEOGEN) ) has provided an announcement. Neogen Che...
09-29 02:53
CHARBONE Hydrogen announces $2M convertible debentures replacement
CHARBONE HYDROGEN (TSXV:CH:CA) announced on Thursday the signature of replacement debentures of an amount of $2.05M by amending certain terms of the secured convertible debentures of the company that ...
09-19 13:32
哈密通慧德向国富氢能下单1.5亿元绿氢设备采购合同
2025年8月18日，国富氢能全资控股公司新疆国富铭志氢能科技有限责任公司（以下简称 “国富铭志”）与哈密通慧德绿色铸造有限公司（以下简称 “哈密通慧德”）在哈...
08-19 08:33
Oragenics Q2 2025 Shareholder Update
Oragenics, Inc. has achieved significant milestones in developing ONP-002, aiming to become the first FDA-approved pharmacological treatment for concussion. The company's proprietary intranasal delivery technology offers rapid brain delivery, bypassing systemic circulation, and is expected to initiate Phase IIa trials in Q3 2025. Key achievements include human research ethics committee approval, partnerships with Southern Star Research and Sterli...
08-11 12:45
